Naloxegol for Treatment of Opioid-Induced Constipation in the Pediatric Intensive Care Unit.

Author: CrawleyLee, GillettEthan L, LayesClint A, SchexnayderStephen M

Paper Details 
Original Abstract of the Article :
Opioid-induced constipation is a common problem in critically ill children requiring sedation. Naloxegol is an oral U.S. Food and Drug Administration (FDA)-approved peripherally acting mu-opioid receptor antagonist for chronic opioid-induced constipation use in adults, but data on its use in childre...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/00099228221142129

データ提供:米国国立医学図書館(NLM)

Opioid-Induced Constipation: A Challenging Desert in the World of Critical Care

This research, published in the field of critical care medicine, tackles the challenge of opioid-induced constipation, a common problem in critically ill children. The authors explore the use of naloxegol, a peripherally acting mu-opioid receptor antagonist, in this population. Their retrospective analysis shows that naloxegol can be effective in increasing stool output in critically ill children without increasing opioid withdrawal symptoms. This research is like finding a hidden oasis in the desert of opioid-induced constipation, offering a safe and effective way to alleviate this common problem.

Naloxegol: A Potential Solution for Opioid-Induced Constipation

The researchers found that naloxegol was effective in increasing stool frequency in critically ill children receiving opioids. They also found that the use of naloxegol did not lead to a significant increase in opioid withdrawal symptoms. This finding suggests that naloxegol may be a valuable adjunctive therapy for opioid-induced constipation in this population. It's like finding a new and reliable source of water in a desert that is often dry and difficult to navigate.

Navigating the Desert of Critical Care: Finding Solutions for Children

This research highlights the importance of finding effective and safe solutions for opioid-induced constipation in critically ill children. It demonstrates the potential for naloxegol to be a valuable tool in managing this challenging condition. It's like a camel caravan finding a safe passage through a treacherous desert, ensuring the health and well-being of its members.

Dr.Camel's Conclusion

This research offers hope for a better management of opioid-induced constipation in critically ill children. The findings suggest that naloxegol may be an effective and safe option for this population. It's a reminder that even in the harsh desert of critical care, we can find solutions that improve the health and well-being of our patients.

Date :
  1. Date Completed 2023-06-12
  2. Date Revised 2023-06-12
Further Info :

Pubmed ID

36475875

DOI: Digital Object Identifier

10.1177/00099228221142129

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.